Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Myelodysplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06046313
What this trial is testing

Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
First Affiliated Hospital of Zhejiang University 120
Early research (Phase 1)Study completedNCT01471067
What this trial is testing

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma+2 more
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT00433745
What this trial is testing

Wilm's Tumor 1 (WT1) Peptide Vaccine for High Risk Hematologic Malignancy

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)
National Heart, Lung, and Blood Institute (NHLBI) 4
Early research (Phase 1)Study completedNCT02122081
What this trial is testing

Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+12 more
Sumithira Vasu 33
Testing effectiveness (Phase 2)WithdrawnNCT04264806
What this trial is testing

Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Ended earlyNCT04812548
What this trial is testing

Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants

Who this might be right for
Myelodysplastic Syndrome (MDS)
Novartis Pharmaceuticals 20
Not applicableUnknownNCT02905552
What this trial is testing

Myelodysplasic Syndromes and Risk Factors for Infection

Who this might be right for
Myelodysplastic Syndrome (MDS)InfectionRisk Factors+1 more
Assistance Publique - Hôpitaux de Paris 320
Not applicableUnknownNCT01252784
What this trial is testing

Reduced-intensity Conditioning Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Myelodysplastic Syndrome
Cooperative Study Group A for Hematology 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02944955
What this trial is testing

BLEX 404 Oral Liquid in Patients With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-Risk Myelodysplastic Syndrome (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Who this might be right for
Myelodysplastic Syndrome (MDS)
BioLite, Inc. 52
Large-scale testing (Phase 3)Looking for participantsNCT06641414
What this trial is testing

Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

Who this might be right for
Higher-risk Myelodysplastic Syndrome
Ascentage Pharma Group Inc. 490
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Early research (Phase 1)Active Not RecruitingNCT05139004
What this trial is testing

90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
City of Hope Medical Center 7
Not applicableStudy completedNCT01241357
What this trial is testing

High-Tc Susceptometer to Monitor Transfusional Iron Overload

Who this might be right for
Transfusional Iron OverloadThalassemia MajorSickle Cell Disease+2 more
Columbia University 99
Testing effectiveness (Phase 2)Ended earlyNCT00655395
What this trial is testing

Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Viron Therapeutics Inc 25
Early research (Phase 1)Temporarily pausedNCT04485065
What this trial is testing

Safety and Efficacy of IBI188 With Azacitidine in Subjects With Newly Diagnosed Higher Risk MDS

Who this might be right for
Myelodysplastic Syndromes
Innovent Biologics (Suzhou) Co. Ltd. 120
Early research (Phase 1)Study completedNCT01169012
What this trial is testing

PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more
UNC Lineberger Comprehensive Cancer Center 13
Not applicableEnded earlyNCT00443300
What this trial is testing

Effectiveness of Protected Environment Rooms for AML and MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)WithdrawnNCT05367401
What this trial is testing

Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT05835011
What this trial is testing

Oral Decitabine/Cedazuridine in Combination With Magrolimab in Participants With Intermediate- to Very High-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Astex Pharmaceuticals, Inc. 2
Early research (Phase 1)Not Yet RecruitingNCT07617363
What this trial is testing

ATRN-119 in Combination With Decitabine in Patients With TP53-Mutated AML or Higher-Risk MDS

Who this might be right for
Acute Myeloid LeukemiaHigh-risk Myelodysplastic Syndrome
Washington University School of Medicine 27
Next Page